Newsletter

Gregory C. Ippolito, Ph.D. brings deep expertise in approaches that reveal fundamental mechanisms of a body’s immune response to infection, as well as responses where antibodies mistakenly attack healthy organs and tissues in autoimmune disorders such as lupus. He and collaborators have identified antibody repertoires elicited by vaccines or treatments. They designed a protocol that … Read more

Paolo Casali, M.D. has spent almost 5 decades in the areas if immunology, microbiology and molecular genetics. Dr. Casali studies how certain genes are turned on or off in the immune system and looks at how these changes affect the body’s ability to make antibodies; proteins that help fight infections. The Casali lab studies how … Read more

BioMedSA’s Board of Directors approved 4 new memberships in June 2024: Eppendorf, Lone Star National Bank, Pizarro Allen, and Raven Innovations. Eppendorf is a German based company that seeks to support research in academic, commercial, and industrial spaces by developing and manufacturing a variety of products and services for use in laboratories in pharmaceutical, biotech, … Read more

Dr. Alison Wiesenthal is the current Chair of the Department of Rehabilitation Medicine at Brooke Army Medical Center (BAMC). Stepping into this role in March of 2020, Wiesenthal became the first civilian to hold the position. She founded the first interdisciplinary Palliative Care Service to the Department of Defense in 2017. Her current role also … Read more

Dr. Laurence Morel is investigating the mechanisms of lupus pathogenesis. The ultimate goal of her work is to establish better clinical management and therapeutic targets by identifying lupus susceptibility in genes or pathways.  Her current focus is CD4 T cells and B cells. In 2022, the University of Texas System awarded Dr. Morel $1.4M to establish … Read more

BioMedSA’s Board of Directors approved 3 new memberships in April 2024: GoldiloxBio, Maribel Gonzalez and TECHspace. GoldiloxBio develops novel assays to provide predictive pre-clinical toxicity and efficacy testing to the BioPharma market. Maribel Gonzalez is the Co-Founder and Owner of Vitality Chronic Care Management as well as a leader in the development of Platelet-Rich Plasma … Read more

  After a rigorous application and acceptance process, pitch development support and in-person pitching, the Biofest Invest 2024 winner is NeuraStasis, as startup.  NeuraStasis seeks to improve health outcomes for stroke survivors through the use of neurostimulation. The Houston startup was founded in 2021 by Dr. Kirt Gill and Joe Upchurch in an effort to … Read more

Biofest Days was a week-long celebration of the Healthcare and Bioscience industry held from April 16-April 20 that highlighted the assets and support structure of a thriving and growing ecosystem. Centering around the Biofest Invest startup conference and pitch competition, BioMedSA extended the invitation to local, regional, and national organizations to participate in Biofest Days … Read more

BioMedSA’s Board of Directors approved 2 new memberships in February 2024: ALS Association and Capital Factory Established in 1985, the ALS Association (Amyotrophic Lateral Sclerosis Association) is the only national nonprofit organization fighting ALS on every front. Seeking to lead the way in global research, providing assistance for people with ALS, coordinating multidisciplinary care through … Read more

Partnering with large and mid-sized biopharma companies is a key part of the journey for biotech companies looking to develop, market, or deploy new assets and medical interventions. Whether it’s to gain access to experts, funding, facilities, or industry knowledge, you first need to get on a partner’s radar.   The art and science of success … Read more